|
 |
5-ASAThis page contains recent news articles, when available, and an overview of 5-ASA but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....more than 120 patients who took one 210-mg tablet per day for eight weeks or placebo as an add-on therapy to oral mesalazine or other 5-ASA derivatives. FDA news (subscription), Cosmo Pharma's colitis treatment Herparin reaches primary ... - Apr 20, 2008 ...colitis were using one 210 mg tablet per day for 8 weeks as an add on therapy to oral mesalazine or other 5-ASA derivatives, the company said. CNNMoney.com Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the ... - Mar 26, 2008 Mesalamines are a part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA), a well-established drug of choice and often a Trading Markets (press release), AGI Therapeutics, plc announces Financial results for the twelve ... - Apr 3, 2008 AGI believes that its 4-ASA product may offer certain advantages compared with current 5-ASA based therapies which are commonly used to treat UC, FOXBusiness WKU track squads compete - Apr 14, 2008 Also claiming two top-three finishes was Andrew Campbell, who was third in the shot with a put of 46-11 and third in the discus with a throw of 140-5. Asa Bowling Green Daily News, Medical Futures signs North American licensing rights to New ... - Apr 7, 2008 About MUTAFLOR(R) MUTAFLOR(R) has data proving equal efficacy when compared to 5-ASA products in remission maintenance of Ulcerative Colitis. Canada NewsWire (press release), Nationwide Awards Recognize Nurses, Associates and Nursing Teams ... - Mar 26, 2008 1 most-prescribed 5-ASA therapy for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).(1) Additional information about Asacol can be found PR Newswire (press release), Shire Launches Patient Education Forums on Better Managing the ... - 10 Mar 2008 LIALDA is part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA). 5-ASA is a well-established drug of choice and often a PharmaLive.com (press release), Salix Pharmaceuticals Reports 4Q2007 and FY2007 Results - Mar 3, 2008 We believe this once-a-day, delayed and extended release formulation, if approved, should provide reliable and effective delivery of mesalamine, or 5-ASA, Business Wire (press release), Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial In ... - Feb 11, 2008 Current first-line anti-inflammatory drugs for the treatment of UC are topical 5-ASA compounds such as sulfasalazine-, olsalazine- and mesalimine-based Medical News Today (press release), BUYINS.NET: (SLXP) SqueezeTrigger Price is $13.437. There is ... - Feb 21, 2008 The product belongs to the category of oral-branded prescription products containing the active therapeutic agent 5-ASA. The Company competes with Trading Markets (press release), First and Only Once-Daily Mesalamine for Active, Mild to Moderate ... - Jan 29, 2008 ...ulcerative colitis patients (n equals 451) and gastroenterologists (n equals 300) reflected this difficulty of adherence with current 5-ASA therapy. Canada NewsWire (press release), Nationwide Survey Reveals Differing Physician and Patient ... - Dec 7, 2007 5-ASA is a well-established drug of choice and often a first-line treatment for UC. LIALDA is indicated for the induction of remission in patients with Reuters Study Data Show Asacol(R) (Mesalamine) is Effective in Treating ... - Dec 5, 2007 ..."A common misperception among physicians is that all oral 5-ASA studies have included proctitis patients; however, this is not the case," says Dr. Seymour CNNMoney.com Mezavant XL launched in the UK - Nov 20, 2007 Mezavant XL™ is the first and only EU approved once-daily oral formulation of mesalamine 5-aminosalicyclic acid (5-ASA), a first-line treatment for patients PharmaLive.com (press release), Alizyme PLC - COLAL-PRED Licensing - Nov 29, 2007 The ulcerative colitis market is currently dominated by anti-inflammatorysteroids and 5-ASA products, which have safety and/or efficacy issues. Reuters Survey Reveals Differing Physician, Patient Perceptions - Dec 8, 2007 ...if their physician advised that they do so, and 89 percent of patients report that they would be interested in trying aonce-daily 5-ASA medication. eMaxHealth.com, Perceptions of physicians and patients differ on the impact of ... - Dec 8, 2007 ...medication provided their physician advised that they do so, and 89pct of patients reported that they would prefer to try a once-daily 5-ASA medication. DailyIndia.com, Guidelines for Ulcerative Colitis Management Reviewed - Nov 13, 2007 For isolated proctitis, rectal therapy with 5-aminosalicylic acid (5-ASA) compounds is recommended, but oral 5-ASA compounds and oral corticosteroids are Medscape (subscription) Ulcerative colitis - Oct 30, 2007 ...(5 ASA = 5-aminosalicylic acid.) Table 6. Common Medical Therapies for Patients with Ulcerative Colitis note: Listed in order of pharmacologic treatments AAFP News Now Salix Pharmaceuticals Reports 3Q2007 Results - Nov 6, 2007 ...nine months of 2007 remained stable compared to the first nine months of 2006 – commendable performance in the highly competitive 5-ASA marketplace. Business Wire (press release), Crohn''s Disease Drug Market Will More Than Double to $4 Billion ... - Nov 13, 2007 However, the 5-ASA class of aminosalicylates will see a steady decline in patient share as physicians begin to move away from these agents and use more 金�界, MMX Mesalazine Therapy Relieves Ulcerative Colitis Symptoms ... - Oct 29, 2007 ...high-strength formulation of 5-aminosalicyclic acid (mesalazine, 1.2 g per tablet) that uses MMX technology to deliver 5-ASA throughout the colon. DG News Further upgrade to 2007 financial guidance based on strong revenue ... - Nov 1, 2007 Shire’s GI franchise now has more than 23% of the US oral 5-ASA market. We are now preparing for the first European launches of this product. PharmaLive.com (press release), Warning signs everywhere with Cleveland school shooter - Oct 12, 2007 At age 5, Asa is shot in the arm with a pellet gun. His mother told police the children's absent father gave them three pellet guns. ConnieTalk, Hollis-Eden Pharmaceuticals Presents Positive Data Demonstrating ... - Oct 8, 2007 Current first line anti-inflammatory medications for the treatment of UC are topical 5-ASA compounds such as sulfasalazine, olsalazine and mesalimine based Genetic Engineering News (press release), Asacol® 800mg Mr Tablets Approved For Ulcerative Colitis (UC ... - Oct 11, 2007 The two ASCEND (Assessing the Safety and Clinical Efficacy of a New Dose of 5-ASA) studies demonstrated that for patients with moderately active ulcerative Medical News Today (press release), Salix Pharmaceuticals Announces Co-Promotion Agreement for Balsalazide - Sep 5, 2007 The ability of balsalazide to deliver 99% of active 5-ASA in the colon makes this unique azo-bonded product a valuable treatment option. Business Wire (press release), Spurs Reserves v Birmingham Reserves, 03.09.07 - Sep 4, 2007 Radek Cerny 1 Artur Krysaik Phil Ifil 2 David Joyce Cian Hughton 3 Shaun Timmins Jake Livermore 4 Martin Taylor Michael Dawson(C) 5 Asa Hall Leigh Mills Spurs Oddysey, Gut Feeling - Aug 13, 2007 One new drug to treat IBD is 5-aminosalicylic acid (5-ASA), which is also called mesalamine. Corticosteroids such as prednisone suppress the immune system New Haven Register (subscription), Salix Announces Statistically Significant Top-Line Results of a ... - Sep 5, 2007 We believe this combination of delayed followed by extended release should result in a very reliable and effective delivery of mesalamine, or 5-ASA, Business Wire (press release), Community sports calendar - Jul 11, 2007 Tallahassee.com,1-5. ASA Men's Church National Championship Finals - Aug. 10-12. For information about any of these events, call Wayne Funderburke at 891-3866. Salix Pharmaceuticals Reports 2Q2007 Results - Aug 3, 2007 PharmaLive.com (press release),Balsalazide's unique, azo-bonded prodrug formulation provides for excellent efficiency in delivery of the anti-inflammatory agent 5-ASA to the colon. July 4th events - Jun 28, 2007 Akron Beacon Journal,Band concert with Special Request in Rehm Performing Arts Pavilion at 7 pm July 5. ASA Girls Fast Pitch Softball Tournament July 6-8. LMS: Racing season news - Jun 12, 2007 Motorsport.com,When asked about his new endeavor, Luches commented; 5. ASA Late Model Series Southern Division teams to dial in at the Birmingham (AL) International LMS: Racing season news - Jun 4, 2007 Motorsport.com,5. ASA Late Model Series Driver, Ryan Lawler wins his second straight PASS South Series Feature of the 2007 season. Anderson, South Carolina (06/04/2007): New Study Suggests Number of Pills Not a Factor When it Comes to ... - Jun 5, 2007 PR Newswire (press release),1 most-prescribed 5-ASA therapy for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).(III) Additional information about Asacol can be Analysis Of Ulcerative Colitis (UC) Remission Rates From Long-term ... - 25 May 2007 Medical News Today (press release),Another post-hoc analysis of the 303 extension study investigated those patients on a 5-ASA who achieved remission or were deemed to be sufficiently Two New Analyses - Quality of Life and Medication Adherence, Offer ... - May 22, 2007 PR-Inside.com (Pressemitteilung),The study, "Predictors of 5-ASA Prescription Persistence in Patients with Ulcerative Colitis," sought to identify factors for 5-ASA therapy non- adherence Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term ... - May 22, 2007 Earthtimes.orgAnother post-hoc analysis of the 303 extension study investigated those patients on a 5-ASA who achieved remission or were deemed to be sufficiently Ligand rosiglitazone for active ulcerative colitis - May 22, 2007 SpiritIndia,Patients who have not responded to or were intolerant of 5-ASA were given either 4mg of rosiglitazone or a placebo twice daily for 12 weeks. Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term ... - May 22, 2007 PR Newswire (press release),Long-term remission rates regardless of 5-ASA treatment (abstract # T1295) Another post-hoc analysis of the 303 extension study investigated those patients Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many ... - May 17, 2007 PR Newswire (press release),LIALDA is part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA). 5-ASA is a well-established drug of choice and often a Salix Pharmaceuticals Reports 1Q2007 Results - May 8, 2007 PharmaLive.com (press release),Year-over-year demand for COLAZAL, the initial offering in our inflammatory bowel disease product line, grew 5.3% versus 3.8% for the 5-ASA market, 50 Ways To Go Green: Part 5 - Apr 23, 2007 WNBC,50 Ways To Go Green: Part 5 Asa Aarons Reports The final ten ways you can help protect the environment. URL:. Never knew I could do so much for the Cleaning Product Ahead Of Green Craze - Apr 24, 2007 NBC5i.com,50 Ways To Go Green: Part 5 Asa Aarons Reports The final ten ways you can hel... Green Weekend North Texas Goes Green North Texans spent Earth Day w. Dietary Factors in the Modulation of Inflammatory Bowel Disease - Mar 28, 2007 Medscape (subscription)Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. Nationwide Awards Recognize Nurses, Associates and Nursing Teams ... - Mar 30, 2007 Drug Newswire (press release),1 most-prescribed 5-ASA therapy for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD). Additional information about Asacol can be found by Asacol® Sponsors ScriptAssist Nurse Call-Back Program to Address ... - 18 Jan 2007 EndoNurse,2 Further, a recent analysis of 1680 UC patients who initiated 5-ASA treatment showed that approximately one-third of patients were no longer on their 5-ASA Asacol(R)(Mesalamine) Sponsors ScriptAssist Nurse Call-Back ... - 18 Jan 2007 PR Newswire (press release),2) Further, a recent analysis of 1680 UC patients who initiated 5-ASA treatment showed that approximately one-third of patients were no longer on their Colazal® Pediatric Indication Approved First 5-ASA Approved for ... - 18 Jan 2007 dBusinessNews Triangle (press release),We believe this approval speaks, in large part, to the tolerability of our unique, azo-bonded prodrug formulation of 5-ASA, which is specifically designed Market Report -- In Play (SHPGY) - Jan 17, 2007 MSN MoneyMesalamines are a part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA), a well-established drug of choice and often a News For Your Web Site - Jan 16, 2007 dBusinessNews Chicago (press release),...of the greatest collections of players and major champions in the history of 16" softball who played in the '80s, and won 5 ASA National Championships. UPDATE 1-Salix drug wins US OK for bowel disease in youth - Dec 20, 2006 ReutersColazal is an anti-inflammatory drug in a class known as 5-aminosalicyclic acid, or 5-ASA, products, Salix said in a statement. Colazal is the only 5-ASA Colazal® Pediatric Indication Approved First 5-ASA Approved for ... - Dec 20, 2006 dBusinessNews Triangle (press release),We believe this approval speaks, in large part, to the tolerability of our unique, azo-bonded prodrug formulation of 5-ASA, which is specifically designed UPDATE 1-Salix drug wins US OK for bowel disease in youth - Dec 20, 2006 ReutersColazal is an anti-inflammatory drug in a class known as 5-aminosalicyclic acid, or 5-ASA, products, Salix said in a statement. Colazal is the only 5-ASA Shire to get European approval for its ulcerative colitis drug - Dec 18, 2006 DrugResearcher.com,MMX mesalazine is a novel, high-strength oral formulation of the 5-aminosalicylate (5-ASA) mesalazine. The MMX technology uses a proprietary system to : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |